Overview of Dr. Badie
I am a board certified neurosurgeon and current vice chair & professor, Department of Surgery and chief, Division of Neurosurgery at City of Hope in Duarte, California. I am also the director of the Brain Tumor Program at City of Hope.
I am an expert in the field of surgical neuro-oncology, and our Brain Tumor Program and Division of Neurosurgery is leading groundbreaking research into nanotechnology as a tool for delivering cancer-fighting drugs directly into tumors, in a minimally invasive manner. Education & Training UCLA Medical Center Residency UCLA Medical Center Internship David Geffen School of Medicine at UCLA MedicalSchool Certifications & Licensure Awards, Honors, & Recognition America's Top Doctors Castle Connolly, 2009-2014 Top Doctors:LA Area Castle Connolly, 2013 America's Top Doctors for Cancer Castle Connolly, 2005-2013 Join now to see all Publications & Presentations PubMed
Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.
Mirzaei, H. R.,Rodriguez, A.,Shepphird, J.,Brown, C. E.,Badie, B.> ;Front Immunol. 2019 May 03
A brainstem mass of Müllerian type Epithelial Origin without any primary cancer source.
Fiani, B.,Quadri, S. A.,Farooqui, M.,D'Apuzzo, M.,Rosser, R. J.,Berman, B. W.,Noel, J.,Xin, X. S.,Badie, B.,Ramachandran, A.,Siddiqi, J.> ;J Clin Neurosci. 2018 Oct 20
S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth.
Gao, H., Zhang, I. Y., Zhang, L., Song, Y., Liu, S., Ren, H., Liu, H., Zhou, H., Su, Y., Yang, Y., Badie, B.> ;Cancer letters. 2018 Aug 5 Join now to see all Press Mentions City of Hope Investigators Receive $4.1M for Clinical Trial Applying CAR T Cells Targeting Dangerous Brain Cancer October 21, 2019 City of Hope Scientist Receives $9.28 Million for CAR T Cell Immunotherapy Clinical Trial for Patients with HER2-Positive Breast Cancer That Has Spread to the Brain August 13, 2019 Mustang Bio Announces Presentations on CAR T Therapies at 4th Annual CAR-TCR Summit 2018 September 04, 2018 Join now to see all Grant Support Novel Cell Delivery Method for Brain Tumor Therapy National Cancer Institute (NCI) 2014–Present Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma Therapy NINDS 2013–Present Role Of Receptor For Advanced Glycation END Product (RAGE) Pathway In Brain Tumor National Cancer Institute 2011 Application Of Carbon Nanotubes For Macrophage Activation In Brain Tumor Models National Cancer Institute 2009–2010